China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China flag China · Delayed Price · Currency is CNY
18.44
+0.09 (0.49%)
Feb 3, 2026, 1:35 PM CST

SHA:600062 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,2182,8513,4622,6302,8342,410
Trading Asset Securities
200.64--200.49803.58851.95
Cash & Short-Term Investments
2,4192,8513,4622,8313,6383,262
Cash Growth
-10.60%-17.65%22.29%-22.18%11.51%20.73%
Accounts Receivable
2,9052,5992,6332,2111,9782,086
Other Receivables
33.86209.041,363468.9866.1450.5
Receivables
2,9392,8083,9972,6802,0442,137
Inventory
1,6401,5941,6881,9001,6651,289
Prepaid Expenses
----0.59-
Other Current Assets
346.6224.59235.49227.89174.55112.22
Total Current Assets
7,3447,4779,3827,6397,5236,800
Property, Plant & Equipment
4,3494,2384,0463,5712,9572,673
Long-Term Investments
1,1001,0481,016350.29303.43370.08
Goodwill
1,107878.49907.9934.96788.19796.41
Other Intangible Assets
1,7611,7491,7681,6481,1931,094
Long-Term Accounts Receivable
22.362.37----
Long-Term Deferred Tax Assets
140.45135.8140.58127.1973.7752.22
Long-Term Deferred Charges
681.67744.92813792.3723.66569.38
Other Long-Term Assets
508.41412.4129.8103.27114.660.72
Total Assets
17,01416,68618,20315,16513,67612,416
Accounts Payable
680.5835.81740.49750.39847.4848.05
Accrued Expenses
455.752,2961,6911,4961,2831,149
Short-Term Debt
9.5589.0559.4736.954.75-
Current Portion of Long-Term Debt
-12200.250.27--
Current Portion of Leases
-11.3122.4919.4617.84-
Current Income Taxes Payable
162.7243.8465.7277.7859.6258.92
Current Unearned Revenue
154.8174.88293.43194.21201.35146.24
Other Current Liabilities
1,801539.731,706507.17317.31467.45
Total Current Liabilities
3,2644,0034,7793,0822,7312,670
Long-Term Debt
1,1271,090-200--
Long-Term Leases
28.9922.129.9532.9335.43-
Long-Term Unearned Revenue
146.23160.67182.31199.61153.92101.02
Pension & Post-Retirement Benefits
166.21169.64147.55144.18157.75150.43
Long-Term Deferred Tax Liabilities
101.64123.6158.59176.17120.35103.62
Other Long-Term Liabilities
18.245.675.675.061.1114.4
Total Liabilities
4,8535,5745,3033,8403,1993,040
Common Stock
1,0391,0391,0401,0431,0431,043
Additional Paid-In Capital
203.39193.45837.55275.22149.39149.39
Retained Earnings
10,1299,26910,4609,4158,7188,102
Treasury Stock
-37.95-74.36-125.56-175.68--
Comprehensive Income & Other
-15.11-19.31.32-1.43-5.17-0.28
Total Common Equity
11,31910,40812,21310,5569,9059,294
Minority Interest
842.22703.89685.95768.46571.0682.88
Shareholders' Equity
12,16111,11212,89911,32510,4779,377
Total Liabilities & Equity
17,01416,68618,20315,16513,67612,416
Total Debt
1,1661,224312.16289.6158.02-
Net Cash (Debt)
1,2531,6263,1502,5413,5803,262
Net Cash Growth
-37.16%-48.36%23.94%-29.00%9.73%23.67%
Net Cash Per Share
1.211.583.072.453.433.13
Filing Date Shares Outstanding
1,0381,0271,0211,0401,0431,043
Total Common Shares Outstanding
1,0381,0271,0211,0401,0431,043
Working Capital
4,0803,4744,6024,5564,7924,130
Book Value Per Share
10.9010.1311.9610.159.498.91
Tangible Book Value
8,4517,7809,5377,9737,9257,403
Tangible Book Value Per Share
8.147.579.347.677.607.10
Buildings
-3,4523,1622,5792,3142,171
Machinery
-4,3584,0003,3062,7582,578
Construction In Progress
-455.14570.38439.72272.81281.03
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.